The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

Eko Health announced today that the American Medical Association issued a Category III CPT code for its Sensora platform.

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

New research finds that on extremely hot days, people with implanted defibrillators face nearly triple the odds for a ...

The Fibrosis-4 Index (FIB-4) is used to identify adults who don’t have viral ... “Thus, current guidelines focusing on early ...

Dr. Sanjay Rajagopalan said in the release that the study may be the first to link ICD detection of AFib with temperature ...

Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, today announced the ...

Afib tracking is just one of the Apple Watch's suite of health features, which were recently bolstered by the introduction of ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11 percent, a new study shows.

Barua also cautions that the study was not designed to tell whether exercise alone directly reduced the risk of atrial ...

The Category III CPT code reflects SENSORA's growing role as an essential tool in cardiac care and is expected to expand its ...